Choosing a Right to Choose ADHD Provider: How to Pick the Right One in the UK

The main factors to weigh are current waiting times, assessment format, post-diagnosis medication support, shared care success rate, and patient reviews. Waiting times change frequently, so check the provider's website or call them directly for the latest figures rather than relying on information that may be months old.

Assessment format matters more than some people expect. Most Right to Choose providers now use video consultations, but some offer in-person options if you prefer face-to-face. The length and depth of the assessment also varies - some services use a comprehensive multi-hour evaluation, while others are more focused. Neither approach is inherently better, but you should feel comfortable with how your assessment will be conducted.

Post-diagnosis support is where providers differ most. Some offer full titration management, regular follow-up, and direct liaison with your GP for shared care. Others diagnose and then leave you to arrange the next steps yourself. If you want a smoother path to medication, choose a provider that handles titration as part of their service. For more on what ADHD assessments cost across different routes, see our detailed cost guide.

Psychiatry-UK is the most widely known Right to Choose ADHD provider. They handle a large volume of referrals and have established processes for shared care transfers and GP liaison. Assessments are by video. Waiting times have fluctuated - at peak demand they stretched to several months, though they work to reduce this.

Clinical Partners offers both Right to Choose and private ADHD assessments. They are often chosen by people who want flexibility - starting with a Right to Choose referral but having the option to self-fund if the wait is too long. They offer video and in-person assessments at clinics around the UK.

ADHD 360 is another established provider that accepts Right to Choose referrals and is generally well-reviewed for communication and follow-up. Like most providers, they work primarily through video consultations. You can explore our full list of ADHD assessment providers for more options.

Before confirming your referral to a specific provider, ask these questions: What is the current wait from referral to assessment? Is the assessment conducted by video or in person? Who carries out the assessment - a psychiatrist, a specialist nurse, or another clinician? If I receive a diagnosis, do you handle medication titration? What is your process for setting up shared care with my GP? What happens if my GP refuses shared care? Is there a cost at any stage, or is everything covered by the NHS?

A reputable provider will answer these clearly. If you cannot get straight answers, that is worth noting. The quality of communication before your assessment often reflects the quality of support you will receive after it.

If the experience is not meeting your expectations - long delays in communication, cancelled appointments, or concerns about care quality - you have options. You can raise a complaint directly with the provider, contact NHS England's complaints process, or ask your GP to re-refer you elsewhere.

Give the provider a reasonable chance to resolve the issue first. Administrative delays are common across ADHD services because demand is very high. But if you feel the clinical quality is genuinely poor, do not feel obligated to stay. A new referral to a different provider is a valid step. For more on how shared care works after diagnosis, see our shared care guide.

Switching providers mid-assessment or mid-titration is possible but can be complicated. If you have not yet been assessed, switching is straightforward - your GP sends a new referral. If you are partway through titration, the new provider will need your clinical notes from the first one, which can take time to transfer.

The main risk of switching mid-titration is a gap in your medication. Before switching, confirm with the new provider that they can take over without a gap, and ask your current provider to continue prescribing until the handover is complete.